[Basophilic blast crisis in chronic myeloid leukemia]. 1998

J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
Unidad de Hematología, Hospital General Básico, Baza, Granada.

Acute basophilic leukaemia is usually characterized by a very rapid clinical course, hyperhistaminemia, resistance to antineoplastic therapy and early death due to complications related to disease. This entity is a rare condition, accounting for less than two percent of all haematopoietic malignancies. Most of the case reports are basophilic blast crisis in patients with a previous lympho or myeloproliferative disorder. A 62-year-old woman who was diagnosed as Philadelphia positive chronic myelogenous leukaemia after four years of evolution developed a basophilic blast crisis, whose characteristics are reported. Accompanying this transformation there was also a cytogenetic change. Despite chemotherapy the patient died of disease progression.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001752 Blast Crisis An advanced phase of chronic myelogenous leukemia, characterized by a rapid increase in the proportion of immature white blood cells (blasts) in the blood and bone marrow to greater than 30%. Blast Phase,Blast Crises,Blast Phases,Crises, Blast,Crisis, Blast,Phase, Blast,Phases, Blast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015464 Leukemia, Myelogenous, Chronic, BCR-ABL Positive Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. Granulocytic Leukemia, Chronic,Leukemia, Granulocytic, Chronic,Leukemia, Myelocytic, Chronic,Leukemia, Myelogenous, Chronic,Leukemia, Myeloid, Chronic,Myelocytic Leukemia, Chronic,Myelogenous Leukemia, Chronic,Myeloid Leukemia, Chronic,Leukemia, Chronic Myelogenous,Leukemia, Chronic Myeloid,Leukemia, Myelogenous, Ph1 Positive,Leukemia, Myelogenous, Ph1-Positive,Leukemia, Myeloid, Ph1 Positive,Leukemia, Myeloid, Ph1-Positive,Leukemia, Myeloid, Philadelphia Positive,Leukemia, Myeloid, Philadelphia-Positive,Myelogenous Leukemia, Ph1-Positive,Myeloid Leukemia, Ph1-Positive,Myeloid Leukemia, Philadelphia-Positive,Chronic Granulocytic Leukemia,Chronic Granulocytic Leukemias,Chronic Myelocytic Leukemia,Chronic Myelocytic Leukemias,Chronic Myelogenous Leukemia,Chronic Myelogenous Leukemias,Chronic Myeloid Leukemia,Chronic Myeloid Leukemias,Granulocytic Leukemias, Chronic,Leukemia, Chronic Granulocytic,Leukemia, Chronic Myelocytic,Leukemia, Ph1-Positive Myelogenous,Leukemia, Ph1-Positive Myeloid,Leukemia, Philadelphia-Positive Myeloid,Leukemias, Chronic Granulocytic,Leukemias, Chronic Myelocytic,Leukemias, Chronic Myelogenous,Leukemias, Chronic Myeloid,Leukemias, Ph1-Positive Myelogenous,Leukemias, Ph1-Positive Myeloid,Leukemias, Philadelphia-Positive Myeloid,Myelocytic Leukemias, Chronic,Myelogenous Leukemia, Ph1 Positive,Myelogenous Leukemias, Chronic,Myelogenous Leukemias, Ph1-Positive,Myeloid Leukemia, Ph1 Positive,Myeloid Leukemia, Philadelphia Positive,Myeloid Leukemias, Chronic,Myeloid Leukemias, Ph1-Positive,Myeloid Leukemias, Philadelphia-Positive,Ph1-Positive Myelogenous Leukemia,Ph1-Positive Myelogenous Leukemias,Ph1-Positive Myeloid Leukemia,Ph1-Positive Myeloid Leukemias,Philadelphia-Positive Myeloid Leukemia,Philadelphia-Positive Myeloid Leukemias
D015471 Leukemia, Basophilic, Acute A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse. Basophilic Leukemia, Acute,Acute Basophilic Leukemia,Acute Basophilic Leukemias,Basophilic Leukemias, Acute,Leukemia, Acute Basophilic,Leukemias, Acute Basophilic
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
January 1983, Folia haematologica (Leipzig, Germany : 1928),
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
January 2023, Autopsy & case reports,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
January 2014, European journal of haematology,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
January 1996, Leukemia research,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
April 1989, Sangre,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
August 2006, The Korean journal of laboratory medicine,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
January 1996, Haematologica,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
January 1991, Leukemia & lymphoma,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
December 2008, Haematologica,
J R García Fernández, and M A montalbán, and M L Martín, and M C Ortiz, and M A Martínez, and A García Marcilla
October 1998, Schweizerische medizinische Wochenschrift,
Copied contents to your clipboard!